GM Beat the Market by 33 Points. What That Leaves Out
General Motors stock returned 50.6% in the year to October 14, 2026, while the S&P 500 gained 17.3% over the same period, as reported by Yahoo Finance.
The comparison puts a single company's stock against a capitalization-weighted market index, where larger companies have more influence. The period measured is the 12 months ending October 14. Both numbers are headline returns.
The difference is 33.3 percentage points. GM compounded at roughly 2.9 times the rate of the benchmark.
The broader context here is what that lead does and does not settle. A gap that large swamps any plausible difference from fees or tracking drag, and beats what asset allocation alone usually adds in one year. It is still not alpha, which means return after adjusting for market exposure (beta) and common factors. A stock that swings more than the market will beat it in a broad rally, with no company-specific edge. Without data on how GM moves with the market, that company-specific, or residual, return cannot be isolated.
In my view, attribution is the missing discipline. Headline price return mixes earnings revisions, a rerating where investors pay more for each dollar of earnings, cash paid out to shareholders, and the starting valuation. Two endpoints hide the path. A 50.6% trailing gain fits both steady compounding and a fall followed by a sharp rebound. Volatility, maximum drawdown and trading turnover around the move decide how much of that gain a large holder could actually have kept.
Looking at what this means for portfolios measured against a benchmark, the arithmetic cuts both ways. A 33-point excess is a large deviation if held overweight, and a large missed gain if held underweight. That describes active risk, not quality. Concentration builds fast. A reliability gauge like the information ratio has no meaning when estimated from one observation, and stretching one strong year into the future invites extrapolation error.
For risk oversight, the useful questions look forward and are not answered by past price. What market exposure does the position carry now. What trading liquidity would support buying or selling at size. How closely the GM-specific part moves with existing cyclical and value holdings. Whether market prices already reflect the momentum that just occurred. Price records what was paid for bearing risk after the fact. It does not list the risks taken.
There is also a denominator problem to keep in mind. Trailing returns hinge on the starting price, which may have reflected gloom, optimism or simple drift in index membership. The S&P 500 itself changes over 12 months as weights and sector leadership shift. Comparing one stock to a changing basket over a fixed window is useful shorthand. It is not a controlled experiment.
